Publications by authors named "P V Marquez"
Importance: Preterm infants are recommended to receive most vaccinations at the same postnatal age as term infants. Studies have inconsistently observed an increased risk for postvaccination apnea in preterm infants.
Objective: To compare the proportions of hospitalized preterm infants with apnea and other adverse events in the 48 hours after 2-month vaccinations vs after no vaccinations.
Background: On June 8, 2021, a new 20-valent pneumococcal conjugate vaccine (PCV20, PREVNAR 20, Pfizer, Inc.) was licensed for use in adults aged ≥ 18 years by the US Food and Drug Administration (FDA).
Objective: To describe reports to the Vaccine Adverse Event Reporting System (VAERS) after administration of the 20-valent pneumococcal conjugate vaccine in adults.
This study aims to develop a solver to calculate the dispersion of emitted odour from the main sources located in a large urban wastewater treatment plant (WWTP). Its seasonal odour impact on surrounding areas, including nearby populations, was also evaluated. Different seasons of the year were studied using the prevailing meteorological conditions in each case, within the framework of a Eulerian model.
View Article and Find Full Text PDFIntroduction: is a yeast-like anamorphic rare fungus commonly found in tropical areas. This case report is the first one located in South America.
Case Report: A 67-year-old patient presented with a 5-year history of right foot pain attributed to foot trauma while at sea 5 years prior.
Article Synopsis
- The study aimed to investigate whether there is an increased occurrence of tinnitus (ringing in the ears) after COVID-19 vaccinations by analyzing data from U.S. vaccine safety surveillance systems.
- Using methods like Bayesian data mining and comparing visit rates, researchers looked at reports of tinnitus following vaccinations from 2020 to 2024.
- The results indicated no disproportionate reports of tinnitus linked to COVID-19 vaccines compared to influenza vaccines, particularly in younger populations, but there were slightly higher rates in individuals aged 65 and older for some COVID-19 vaccines.